(KEMIRA) Kemira - HE

Sector: Basic Materials | Industry: Chemicals | Exchange: HE (Finland) | Market Cap: 2.466m EUR | Total Return: -10.5% in 12m

Water Chemicals, Pulp Chemicals, Bleaching Agents, Sizing Agents
Total Rating 38
Safety 82
Buy Signal -1.02
Chemicals
Industry Rotation: -12.9
Market Cap: 2.85B
Avg Turnover: 2.67M
Risk 3d forecast
Volatility26.3%
VaR 5th Pctl4.17%
VaR vs Median-4.30%
Reward TTM
Sharpe Ratio-0.58
Rel. Str. IBD14.5
Rel. Str. Peer Group5.6
Character TTM
Beta0.318
Beta Downside0.249
Hurst Exponent0.433
Drawdowns 3y
Max DD25.17%
CAGR/Max DD0.23
CAGR/Mean DD0.49
EPS (Earnings per Share) EPS (Earnings per Share) of KEMIRA over the last years for every Quarter: "2021-06": 0.23, "2021-09": 0.29, "2021-12": 0.22, "2022-03": 0.3, "2022-06": 0.3, "2022-09": 0.44, "2022-12": 0.52, "2023-03": 0.64, "2023-06": 0.44, "2023-09": 0.48, "2023-12": 0.52, "2024-03": 0.53, "2024-06": 0.42, "2024-09": 0.41, "2024-12": 0.4109, "2025-03": 0.38, "2025-06": 0.36, "2025-09": 0.39, "2025-12": 0.3, "2026-03": 0.28,
EPS CAGR: -15.40%
EPS Trend: -97.0%
Last SUE: -1.20
Qual. Beats: -1
Revenue Revenue of KEMIRA over the last years for every Quarter: 2021-06: 657.5, 2021-09: 692.7, 2021-12: 718.2, 2022-03: 768.1, 2022-06: 861.4, 2022-09: 971.9, 2022-12: 968.3, 2023-03: 906, 2023-06: 840.1, 2023-09: 828.7, 2023-12: 808.8, 2024-03: 763.3, 2024-06: 733.4, 2024-09: 727.6, 2024-12: 723.7, 2025-03: 708.8, 2025-06: 693.4, 2025-09: 687.7, 2025-12: 663.7, 2026-03: 677.3,
Rev. CAGR: -10.34%
Rev. Trend: -97.7%
Last SUE: -0.22
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: KEMIRA Kemira

Kemira Oyj is a Finland-based chemical company specializing in sustainable chemical solutions for water-intensive industries. The company operates through three primary segments: Water Solutions, Packaging & Hygiene Solutions, and Fiber Essentials, providing products for municipal water treatment, wastewater management, and the global pulp and paper industries.

The business model relies on high barriers to entry within the specialty chemicals sector, where proprietary bleaching and pulping technologies are critical for high-volume fiber production. As a key player in the materials sector, Kemira benefits from the defensive nature of municipal water treatment, which typically maintains stable demand regardless of broader economic cycles.

For a more granular look at the companys financial health and valuation metrics, you may find it useful to explore the data on ValueRay. Founded in 1920, the company leverages advanced digital technologies to optimize chemical dosages and production efficiency for its global client base.

Headlines to Watch Out For
  • Pulp and bleaching chemical demand fluctuates with global paperboard production
  • Municipal water treatment margins depend on energy and raw material costs
  • Packaging and Hygiene segment benefits from plastic-to-paper transition trends
  • Strategic focus on renewable chemicals and bio-based products drives valuation
  • Capital allocation prioritizes dividend stability and selective bolt-on acquisitions
Piotroski VR-10 (Strict) 7.5
Net Income: 165.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.73 > 1.0
NWC/Revenue: 9.84% < 20% (prev 15.60%; Δ -5.76% < -1%)
CFO/TA 0.13 > 3% & CFO 414.9m > Net Income 165.4m
Net Debt (685.7m) to EBITDA (469.2m): 1.46 < 3
Current Ratio: 1.37 > 1.5 & < 3
Outstanding Shares: last quarter (149.6m) vs 12m ago -3.73% < -2%
Gross Margin: 51.40% > 18% (prev 14.49%; Δ 36.91% > 0.5%)
Asset Turnover: 85.18% > 50% (prev 89.92%; Δ -4.74% > 0%)
Interest Coverage Ratio: 9.97 > 6 (EBIT TTM 255.3m / Interest Expense TTM 25.6m)
Altman Z'' 3.12
A: 0.08 (Total Current Assets 998.4m - Total Current Liabilities 730.5m) / Total Assets 3.17b
B: 0.30 (Retained Earnings 948.7m / Total Assets 3.17b)
C: 0.08 (EBIT TTM 255.3m / Avg Total Assets 3.20b)
D: 1.01 (Book Value of Equity 1.58b / Total Liabilities 1.57b)
Altman-Z'' = 3.12 = A
Beneish M -3.65
DSRI: 1.01 (Receivables 424.4m/444.5m, Revenue 2.72b/2.89b)
GMI: 0.28 (GM 14.49% / 51.40%)
AQI: 1.12 (AQ_t 0.32 / AQ_t-1 0.29)
SGI: 0.94 (Revenue 2.72b / 2.89b)
TATA: -0.08 (NI 165.4m - CFO 414.9m) / TA 3.17b)
Beneish M = -3.65 (Cap -4..+1) = AAA
What is the price of KEMIRA shares?

As of June 15, 2026, the stock is trading at EUR 16.99 with a total of 323,936 shares traded.
Over the past week, the price has changed by -5.19%, over one month by -1.39%, over three months by -11.48% and over the past year by -10.54%.

Is KEMIRA a buy, sell or hold?

Kemira has no consensus analysts rating.

Kemira (KEMIRA) - Fundamental Data Overview as of 13 June 2026
Market Cap USD = 2.85b (2.47b EUR * 1.1565 EUR.USD)
P/E Trailing = 15.5872
P/E Forward = 13.4048
P/S = 0.9058
P/B = 1.5573
P/EG = 4.0157
Revenue TTM = 2.72b EUR
EBIT TTM = 255.3m EUR
EBITDA TTM = 469.2m EUR
Long Term Debt = 493.3m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 123.8m EUR (from shortTermDebt, last quarter)
Debt = 948.7m EUR (from shortLongTermDebtTotal, last quarter) + Leases 180.8m
Net Debt = 685.7m EUR (calculated: Debt 948.7m - CCE 263.0m)
Enterprise Value = 3.15b EUR (2.47b + Debt 948.7m - CCE 263.0m)
Interest Coverage Ratio = 9.97 (Ebit TTM 255.3m / Interest Expense TTM 25.6m)
EV/FCF = 15.01x (Enterprise Value 3.15b / FCF TTM 210.0m)
FCF Yield = 6.66% (FCF TTM 210.0m / Enterprise Value 3.15b)
FCF Margin = 7.71% (FCF TTM 210.0m / Revenue TTM 2.72b)
Net Margin = 6.08% (Net Income TTM 165.4m / Revenue TTM 2.72b)
Gross Margin = 51.40% ((Revenue TTM 2.72b - Cost of Revenue TTM 1.32b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.99 (Enterprise Value 3.15b / Total Assets 3.17b)
Interest Expense / Debt = 2.70% (Interest Expense 25.6m / Debt 948.7m)
Taxrate = 22.40% (51.4m / 229.5m)
NOPAT = 198.1m (EBIT 255.3m * (1 - 22.40%))
Current Ratio = 1.37 (Total Current Assets 998.4m / Total Current Liabilities 730.5m)
Debt / Equity = 0.60 (Debt 948.7m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 1.46 (Net Debt 685.7m / EBITDA 469.2m)
Debt / FCF = 3.27 (Net Debt 685.7m / FCF TTM 210.0m)
Total Stockholder Equity = 1.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.18% (Net Income 165.4m / Total Assets 3.17b)
RoE = 9.90% (Net Income TTM 165.4m / Total Stockholder Equity 1.67b)
RoCE = 11.80% (EBIT 255.3m / Capital Employed (Equity 1.67b + L.T.Debt 493.3m))
RoIC = 8.15% (NOPAT 198.1m / Invested Capital 2.43b)
WACC = 5.71% (E(2.47b)/V(3.41b) * Re(7.10%) + D(948.7m)/V(3.41b) * Rd(2.70%) * (1-Tc(0.22)))
Discount Rate = 7.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.82 | Cagr: -1.17%
[DCF] Terminal Value 73.10% ; FCFF base≈246.3m ; Y1≈216.0m ; Y5≈174.5m
[DCF] Fair Price = 14.57 (EV 2.80b - Net Debt 685.7m = Equity 2.12b / Shares 145.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -97.03 | EPS CAGR: -15.40% | SUE: -1.20 | # QB: -1
Revenue Correlation: -97.73 | Revenue CAGR: -10.34% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.26 | Chg30d=-12.07% | Revisions=-33% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.33 | Chg30d=-7.53% | Revisions=-33% | Analysts=3
EPS current Year (2026-12-31): EPS=1.22 | Chg30d=-5.15% | Revisions=-60% | GrowthEPS=-14.6% | GrowthRev=+3.6%
EPS next Year (2027-12-31): EPS=1.59 | Chg30d=+1.82% | Revisions=-40% | GrowthEPS=+29.9% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: -60%